Mammography: Review of the controversy, health disparities, and impact on young african american women

Clinical Journal of Oncology Nursing

Volumn 19, Issue 3, 2015, Pages 52-58

  Kidd, April D ^a   Colbert, Alison M ^a   Jatoi, Ismail ^b  

^a DUQUESNE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

African American women; Breast cancer; Health disparities; Individual risk; Mammography; Patient education

Indexed keywords

ADULT; AFRICAN AMERICAN; BREAST NEOPLASMS; DECISION MAKING; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH DISPARITY; HUMAN; MAMMOGRAPHY; PATIENT PARTICIPATION;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MAMMOGRAPHY; PATIENT PARTICIPATION;

EID: 84929671772     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/15.CJON.E52-E58     Document Type: Article

References (79)

1. American Cancer Society. (2013a). Breast cancer facts and fg-ures 2013–2014. Retrieved from http://cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf
2. American Cancer Society. (2013b). Cancer facts and fgures for African Americans 2013–2014. Retrieved from http://cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036921.pdf
3. American Cancer Society. (2014a). Cancer facts and figures 2014. Retrieved from http://cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
4. American Cancer Society. (2014b). Informed consent. Retrieved from http://cancer.org/acs/groups/cid/documents/webcontent/003014-pdf.pdf
5. Andersson, I., & Janzon, L. (1997). Reduced breast cancer mortality in women under age 50: Updated results from the Malmö Mam-mographic Screening Program. Retrieved from http://jncimono.oxfordjournals.org/content/1997/22/63.full.pdf
6. Beemsterboer, P.M., Warmerdam, P.G., Boer, R., & de Koning, H.J. (1998). Radiation risk of mammography related to benefit in screening programmes: A favourable balance? Journal of Medical Screening, 5, 81–87. doi:10.1136/jms.5.2.81
7. Bertrand, K.A., Tamimi, R.M., Scott, C.G., Jensen, M.R., Pankratz, V.S., Visscher, D., Vachon, C.M. (2013). Mammographic density and risk of breast cancer by age and tumor characteristics. Retrieved from http://breast-cancer-research.com/content/15/6/R104
8. Bjurstam, N., Bjorneld, L., Duffy, S.W., Smith, T.C., Cahlin, E., Eriksson, O., Save-Söderbergh, J. (1997). The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer, 80, 2091–2099. doi:10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#
9. Bjurstam, N., Bjorneld, L., Warwick, J., Sala, E., Duffy, S.W., Nys-trom, L., Wahlin, T. (2003). The Gothenburg breast screening trial. Cancer, 97, 2387–2396. doi:10.1002/cncr.11361
10. Bleyer, A., & Welch, H.G. (2012). Effect of three decades of screening mammography on breast-cancer incidence. New England Journal of Medicine, 367, 1998–2005. doi:10.1056/NEJMoa1206809
11. Bosse, K., Graeser, M., Goßmann, A., Hackenbroch, M., Schmutzler, R.K., & Rhiem, K. (2014). Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers. Archives of Gynecology and Obstetrics, 289, 663–670.
12. Byrne, S.K., Mary, E.S., & DeShields, T. (2011). Factors associated with why African American women from one urban county use mammography services less. Journal of the National Black Nurses’ Association, 22, 8–14.
13. Calvocoressi, L., Kasl, S.V., Lee, C.H., Stolar, M., Claus, E.B., & Jones, B.A. (2004). A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and white women ages 40 to 79 years. Cancer Epidemiology, Biomarkers, and Prevention, 13, 2096–2105.
14. Calvocoressi, L., Sun, A., Kasl, S.V., Claus, E.B., & Jones, B.A. (2008). Mammography screening of women in their 40s: Impact of changes in screening guidelines. Cancer, 112, 473–480.
15. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine. (2014). IBIS breast cancer risk evaluation tool. Retrieved from http://ems-trials.org/riskevaluator
16. Christie, D. (1977). Screening for breast cancer: The role of mam-mography. Medical Journal of Australia, 2, 398–400.
17. Clark, P.M. (2004). Nongenetic and heritable risk factors. In D.K. Hassey (Ed.), Contemporary issues in breast cancer (2nd ed., pp. 10–24). Boston, MA: Jones and Bartlett.
18. Conway-Phillips, R., & Millon-Underwood, S. (2009). Breast cancer screening behaviors of African American women: A comprehensive review, analysis, and critique of nursing research. ABNF Journal, 20, 97–101.
19. Dailey, A.B., Kasl, S.V., Holford, T.R., & Jones, B.A. (2007). Perceived racial discrimination and nonadherence to screening mam-mography guidelines: Results from the race differences in the screening mammography process study. American Journal of Epidemiology, 165, 1287–1295. doi:10.1093/aje/kwm004
20. DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014). Breast cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 64, 52–62. doi:10.3322/caac.21203
21. Elwood, J.M., Cox, B., & Richardson, A.K. (1993). The effectiveness of breast cancer screening by mammography in younger women. Online Journal of Current Clinical Trials, Doc No. 32.
22. Feldstein, A.C., Perrin, N., Rosales, A.G., Schneider, J., Rix, M.M., & Glasgow, R.E. (2011). Patient barriers to mammography identified during a reminder program. Journal of Women’s Health, 20, 421–428. doi:10.1089/jwh.2010.2195
23. Finney, M.F., Tumiel-Berhalter, L.M., Fox, C., & Jaén, C.R. (2006). Breast and cervical cancer screening for Puerto Ricans, African Americans, and non-Hispanic whites attending inner-city family practice centers. Ethnicity and Disease, 16, 994–1000.
24. Fletcher, S.W. (2011). Breast cancer screening: A 35-year perspective. Epidemiologic Reviews, 33, 165–175. doi:10.1093/epirev/mxr003
25. Foulkes, W.D. (2008). In herited susceptibility to common cancers. New England Journal of Medicine, 359, 2143–2153. doi:10.1056/NEJMra0802968
26. Frankenberg-Schwager, M., & Gregus, A. (2012). Chromosomal instability induced by mammography X-rays in primary human fbroblasts from BRCA1 and BRCA2 mutation carriers. International Journal of Radiation Biology, 88, 846–857. doi:10.3109/09553002.2012.711500
27. Gapstur, S.M., Dupuis, J., Gann, P., Collila, S., & Winchester, D.P. (1996). Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases. Cancer, 77, 1465–1471. doi:10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B
28. Greene, A.L., Torio, C.M., & Klassen, A.C. (2005). Measuring sustained mammography use by urban African-American women. Journal of Community Health, 30, 235–251. doi:10.1007/s10900-005-3703-6
29. Habel, L., & Stanford, J.L. (1993). Hormone receptors and breast cancer. Epidemiologic Reviews, 15, 209–219.
30. Hale, P.J., & Devalpine, M.G. (2014). Screening mammography: Revisiting assumptions about early detection. Journal for Nurse Practitioners, 10, 183–188. doi:10.1016/j.nur pra.2013.11.001
31. Hendrick, R.E., Smith, R.A., & Rutledge, J.H. (1997). Benefit of screening mammography in women ages 30–49: A meta-analysis of randomized controlled trials. Journal of the National Cancer Institute, 22, 87–92.
32. Houssami, N., & Skaane, P. (2013). Overview of the evidence on digital breast tomosynthesis in breast cancer detection. Breast, 22, 101–10 8. doi:10.1016/j.breast.2013.01.017
33. Houssami, N., & Zackrisson, S. (2013). Digital breast tomosynthe-sis: The future of mammography screening or much ado about nothing? Expert Review of Medical Devices, 10, 583–585. doi:10.1586/17434440.2013.835555
34. Institute of Medicine. (2003). Potential of screening to reduce the burden of cancer. In S.J. Curry, T. Byers, & M. Hewitt (Eds.), Fulflling the potential of cancer and prevention and early detection (pp. 156–223). Washington, DC: National Academies Press.
35. Jatoi, I., & Anderson, W.F. (2010). Lessons from the mammogra-phy wars. New England Journal of Medicine, 363, 2569–2570. doi:10.1056/NEJMc1011303
36. Jatoi, I., & Baum, M. (1993). American and European recommendations for screening mammography in younger women: A cultural divide? BMJ, 307, 1481–1483. doi:10.1136/bmj.307.6917.1481
37. Judkins-Cohn, T.M., Kielwasser-Withrow, K., Owen, M., & Ward, J. (2014). Ethical principles of informed consent: Exploring nurses’ dual role of care provider and researcher. Journal of Continuing Education in Nursing, 45, 35–42. doi:10.3928/00220124-20131223-03
38. Kerlikowske, K., Zhu, W., Hubbard, R.A., Geller, B., Dittus, K., Braithwaite, D., O’Meara, E.S. (2013). Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Internal Medicine, 173, 807–816. doi:10.1001/jamainternmed.2013.307
39. Kolb, T.M., Lichy, J., & Newhouse, J.H. (2002). Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations. Radiology, 225, 165–175. doi:10.1148/radiol.2251011667
40. Kremer, M.E., Downs-Holmes, C., Novak, R.D., Lyons, J.A., Silver-man, P., Pham, R.M., & Plecha, D.M. (2012). Neglecting to screen women between the ages of 40 and 49 years with mammogra-phy: What is the impact on breast cancer diagnosis? American Journal of Roentgenology, 198, 1218–1222. doi:10.2214/AJR.11.7200
41. Krizmanich-Conniff, K.M., Paramagul, C., Patterson, S.K., Helvie, M.A., Roubidoux, M.A., Myles, J.D., Sabel, M. (2012). Triple receptor-negative breast cancer: Imaging and clinical characteristics. American Journal of Roentgenology, 199, 458–464. doi:10.2214/AJR.10.6096
42. Kuhl, C.K., Schrading, S., Leutner, C.C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Schild, H.H. (2005). Mam-mography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. Journal of Clinical Oncology, 23, 8469–8476. doi:10.1200/JCO.2004.00.4960
43. Mahon, S.M. (Ed.). (2007). Site-specific cancer series: Breast cancer. Pittsburgh, PA: Oncology Nursing Society.
44. Malmgren, J.A., Parikh, J., Atwood, M.K., & Kaplan, H.G. (2012). Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology, 262, 797–806. doi:10.1148/radiol.11111734
45. Marshall, T. (2005). Informed consent for mammography screening: Modelling the risks and benefits for American women. Health Expectations, 8, 295–305. doi:10.1111/j.1369-7625.2005.00345.x
46. Miller, A.B., To, T., Baines, C.J., & Wall, C. (2002). The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Annals of Internal Medicine, 137, 305–312. doi:10.7326/0003-4819-137-5_Part_1-200209030-00005
47. National Cancer Institute. (2013). SEER cancer statistics review, 1975–2010. Retrieved from http://seer.cancer.gov/csr/1975_2010
48. National Cancer Institute. (2014). Breast cancer risk assessment tool. Retrieved from http://cancer.gov/bcrisktool
49. National Comprehensive Cancer Network. (2014). NCCN Guidelines for Detection, Prevention, and Risk Deduction. Retrieved from http://www.nccn.org
50. Nystrom, L., & Larsson, L.G. (1993). Breast cancer screening with mammography. Lancet, 341, 1531–1532. doi:10.1016/0140-6736(93)91067-V
51. Nystrom, L., Wall, S., Rutqvist, L.E., Lindgren, A., Lindqvist, M., Rydén, S., Larsson, L.G. (1993). Breast cancer screening with mammography: Overview of Swedish randomised trials. Lancet, 341, 973–978. doi:10.1016/0140-6736(93)91067-V
52. Ooi, S.L., Martinez, M.E., & Li, C.I. (2011). Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Research and Treatment, 127, 729–738. doi:10.1007/s10549-010-1191-6
53. Osman, H. (2001). History and development of the doctrine of informed consent. International Electronic Journal of Health Education, 4, 41–47.
54. Patterson, S.K., & Noroozian, M. (2012). Update on emerging technologies in breast imaging. Journal of the National Comprehensive Cancer Network, 10, 1355–1362.
55. Quanstrum, K.H., & Hayward, R.A. (2010). Lessons from the mammography wars. New England Journal of Medicine, 363, 1076–1079. doi:10.1056/NEJMsb1002538
56. Rafferty, E.A., Park, J.M., Philpotts, L.E., Poplack, S.P., Sumkin, J.H., Halpern, E.F., & Niklason, L.T. (2013). Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: Results of a multicenter, multireader trial. Radiology, 266, 104–113. doi:10.1148/radiol.12120674
57. Schrager, S., & Marko, K. (2013). Mammography at age 40? A risk-based strategy. Journal of Family Practice, 62, 630–638.
58. Shapiro, S. (1977). Evidence on screening for breast cancer from a randomized trial. Cancer, 39, 2772–2782. doi:10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K
59. Shapiro, S. (1997). Periodic screening for breast cancer: The HIP Randomized Controlled Trial. Health Insurance Plan. Journal of the National Cancer Institute. Monographs, 22, 27–30.
60. Shapiro, S., Venet, W., Strax, P., Venet, L., & Roeser, R. (1985). Selection, follow-up, and analysis in the Health Insurance Plan Study: A randomized trial with breast cancer screening. National Cancer Institute. Monograph, 67, 65–74.
61. Sims, J.M. (2008a). Your role in informed consent. Part 1. Dimensions of Critical Care Nursing, 27, 70–73. doi:10.1097/01.DCC.0000311599.25216.90
62. Sims, J.M. (2008b). Your role in informed consent: Part 2. Dimensions of Critical Care Nursing, 27, 118–121. doi:10.1097/01.DCC.0000286841.93042.35
63. Skaane, P., Bandos, A.I., Gullien, R., Eben, E.B., Ekseth, U., Haak-enaasen, U., Gur, D. (2013). Comparison of digital mammog-raphy alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology, 267, 47–56. doi:10.1148/radiol.12121373
64. Squiers, L.B., Holden, D.J., Dolina, S.E., Kim, A.E., Bann, C.M., & Renaud, J.M. (2011). The public’s response to the U.S. Preventive Services Task Force’s 2009 recommendations on mammogra-phy screening. American Journal of Preventive Medicine, 40, 497–504. doi:10.1016/j.amepre.2010.12.027
65. Stanford, J.L., & Greenberg, R.S. (1989). Breast cancer incidence in young women by estrogen receptor status and race. American Journal of Public Health, 79, 71–73.
66. Susilo, A.P., Van Dalen, J., Scherpbier, A., Tanto, S., Yuhanti, P., & Ekawati, N. (2013). Nurses’ roles in informed consent in a hierarchical and communal context. Nursing Ethics, 20, 413–425. doi:10.1177/0969733012468467
67. Swift, M., Morrell, D., Massey, R.B., & Chase, C.L. (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. New England Journal of Medicine, 325, 1831–1836. doi:10.1056/NEJM199112263252602
68. Tabar, L., Fagerberg, G., Chen, H.H., Duffy, S.W., Smart, C.R., Gad, A., & Smith, R.A. (1995). Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer, 75, 2507–2517. doi:10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H
69. Tabar, L., Larsson, L.G., Andersson, I., Duffy, S.W., Nystrom, L., & Rutqvist, L.E. (1996). Breast-cancer screening with mammography in women aged 40-49 years. International Journal of Cancer, 68, 693–699. doi:10.1002/(SICI)1097-0215(19961211)68:6<693::AID-IJC1>3.0.CO;2-Z
70. Tabar, L., Vitak, B., Chen, T.H., Yen, A.M., Cohen, A., Tot, T., Duffy, S.W. (2011). Swedish two-county trial: Impact of mammo-graphic screening on breast cancer mortality during 3 decades. Radiology, 260, 658–663. doi:10.1148/radiol.11110469
71. Taylor, A.M. (1992). Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. British Journal of Cancer, 66, 5–9. doi:10.1038/bjc.1992.208
72. Tilanus-Linthorst, M., Verhoog, L., Obdeijn, I.M., Bartels, K., Menke-Pluymers, M., Eggermont, A.,... Brekelmans, C. (2002). A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. International Journal of Cancer, 102, 91–95. doi:10.1002/ijc.10666
73. Tingberg, A., Förnvik, D., Mattsson, S., Svahn, T., Timberg, P., & Zackrisson, S. (2011). Breast cancer screening with tomosynthesis —Initial experiences. Radiation Protection Dosimetry, 147, 180–183. doi:10.1093/rpd/ncr296
74. U.S. Department of Health and Human Services. (2011a). Healthy people 2020. Retrieved from http://healthypeople.gov/2020/default.aspx
75. U.S. Department of Health and Human Services. (2011b). National prevention council: National prevention strategy. Retrieved from http://surgeongeneral.gov/priorities/prevention/strategy
76. U.S. Preventive Services Task Force. (2009). Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 151, 716–726. doi:10.7326/0003-4819-151-10-200911170-00008
77. U.S. Preventive Services Task Force. (2015). Breast cancer screening draft recommendations. Retrieved from http://screeningfor breastcancer.org
78. van Ravesteyn, N.T., Miglioretti, D.L., Stout, N.K., Lee, S.J., Schechter, C.B., Buist, D.S., De Koning, H.J. (2012). Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: A comparative modeling study of risk. Annals of Internal Medicine, 156, 609–617.
79. Ward, J. (1999). Population-based mammographic screening: Does ‘informed choice’ require any less than full disclosure to individuals of benefits, harms, limitations and consequences? Australian and New Zealand Journal of Public Health, 23, 301–304. doi:10.1111/j.1467-842X.1999.tb01260.x